Cargando…

Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers

OBJECTIVE: The aim of this study was to establish a nomogram to predict the recurrence of endometrial cancer (EC) by immunohistochemical markers and clinicopathological parameters and to evaluate the discriminative power of this model. METHODS: The data of 473 patients with stages I–III endometrial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Peng, Huang, Jin, Deng, Ying, Hu, Jing, Huang, Zhen, Jia, Mingzhu, Long, Jiaojiao, Hu, Zhuoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457803/ https://www.ncbi.nlm.nih.gov/pubmed/32922070 http://dx.doi.org/10.2147/CMAR.S263747

Ejemplares similares

A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer
por: Jiang, Peng, et al.
Publicado: (2021)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

Immunohistochemical Markers in Endometrial Cancer
por: Mais, Valerio, et al.
Publicado: (2021)

A Nomogram Model for Predicting Recurrence of Stage I–III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors
por: Jiang, Peng, et al.
Publicado: (2022)

Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma
por: Bounous, Valentina Elisabetta, et al.
Publicado: (2022)

Immunohistochemical Markers in Endometrial Cancer: Latest Updates
por: Mais, Valerio, et al.
Publicado: (2023)

Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters
por: Jiang, Peng, et al.
Publicado: (2022)

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
por: Versluis, M A, et al.
Publicado: (2015)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
por: Salama, Amany, et al.
Publicado: (2019)

Endometrial CD56+ natural killer cells in women with recurrent implantation failure: An immunohistochemical study
por: Babayeva, Gulchin, et al.
Publicado: (2020)

Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020)

Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer
por: Zhang, Jun, et al.
Publicado: (2023)

A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
por: Weinberger, Vit, et al.
Publicado: (2019)

Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas
por: Subbaraya, Sneha, et al.
Publicado: (2020)

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
por: Canioni, Danielle, et al.
Publicado: (2009)

Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8
por: Hernandez-Caballero, Ana I., et al.
Publicado: (2020)

Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2020)

High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study
por: Gao, Ying, et al.
Publicado: (2010)

Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers
por: Zhao, Li, et al.
Publicado: (2019)

Morphological and immunohistochemical diversity of endometrial stromal sarcoma in rats
por: Kumabe, Shino, et al.
Publicado: (2018)

Plasma omega-3 polyunsaturated fatty acids and recurrence of endometrial cancer
por: Li, Peiqin, et al.
Publicado: (2020)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer
por: Zhou, Xin‐Ying, et al.
Publicado: (2022)

Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer
por: Alkushi, Abdulmohsen, et al.
Publicado: (2020)

Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China
por: He, Li, et al.
Publicado: (2013)

Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
por: Jiang, Peng, et al.
Publicado: (2021)

Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models
por: Yang, Bingyi, et al.
Publicado: (2016)

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*
por: Khoury, Thaer, et al.
Publicado: (2006)

Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67
por: Jiang, Peng, et al.
Publicado: (2021)

Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity
por: Horie, Kayo, et al.
Publicado: (2020)

Review of immunohistochemical typing of endometrial carcinoma at the Lagos University Teaching Hospital
por: Dawodu, Olayemi Olubunmi, et al.
Publicado: (2019)

Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers
por: Sanderson, Peter A., et al.
Publicado: (2022)

Silencing nc886, a Non-Coding RNA, Induces Apoptosis of Human Endometrial Cancer Cells-1A In Vitro
por: Hu, Zhuoying, et al.
Publicado: (2017)

An update of the classical Bokhman's dualistic model of endometrial cancer
por: Wilczyński, Miłosz, et al.
Publicado: (2016)

ARG1 is a potential prognostic marker in metastatic and recurrent endometrial cancer
por: Tran, Dinh Nam, et al.
Publicado: (2023)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer
por: Wang, Hui-Ching, et al.
Publicado: (2021)

Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma
por: Kuang, Zhixing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uql9fbr5iiql94h8kg2bfrcuhi